COVID-19 vaccinations summary

Second Boosters Administered 1,127,468
Total Doses Administered 14,020,109
First Boosters Administered 2,788,362
Percentage of 12+ who have completed primary course 83.0%
Percentage of eligible 50+ who have received second booster 57.2%
Percentage of eligible 18+ who have received first booster 71.1%

 

Metrics on this page can use one of two views of the data - An operational view or a person view.

All data comes from the Aotearoa Immunisation Register (AIR). The operational view shows all doses administered in New Zealand. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand. Those who have been vaccinated overseas will only appear in the person view; they will not appear in the operational view. The person view includes all people that are currently alive and in AIR. On 12 June 2024, the estimated population was changed to be sourced from AIR instead of the most recent Health Service User (HSU).

Total vaccinations

  Vaccinations last week Cumulative total
Primary Course Doses (12+) 48 8,027,419
Booster 1 53 2,788,362
Booster 2 252 1,127,468
Booster 3+ 4,181 1,644,117
Paediatric First Dose 4 273,081
Paediatric Second Dose 0 159,085
Infant First Dose 2 243
Infant Second Dose 1 154
Infant Third Dose 0 180
Total doses 4,541 14,020,109

 

This table is an operational view.

Definitions

  • Cumulative total: All vaccinations that have been administered and entered into the Aotearoa Immunisation Register and including Sunday 9 November 2025.
  • Vaccinations last week:  Over the 7 days up to and including Sunday 9 November 2025.

Booster breakdowns

Booster counts by ethnicity

Ethnicity Booster 1 (16-17) Booster 1 (18+) Booster 2 (50+)
Māori 188 260,468 70,124
Pacific Peoples 78 155,721 30,216
Asian 209 470,870 69,563
Other 1,115 1,804,929 708,276
Total 1,590 2,691,988 878,179

 

This table is a person view.

Booster 2 uptake by age group

Age Group Eligible Received Uptake
30 to 34 201,554 41,676 20.7%
35 to 49 645,437 141,356 21.9%
50 to 64 723,281 291,134 40.3%
65+ 811,548 587,045 72.3%

 

This table is a person view.

Vaccine uptake percentage by age band

A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand.

Vaccine uptake percentage by District of residence 12+

A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered.

*Note, this figure does not include 0-11 year olds

*Note, this figure does not include 0-11 year olds

Vaccinations by week

A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

This chart shows the count of vaccinations administered in a given week from the Aotearoa Immunisation Register.

Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.

Adverse events following immunisations (AEFI)

Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.

Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). While Medsafe no longer publishes their COVID-19 vaccine safety reports, they continue to monitor reports of adverse reactions submitted to CARM.

More information